Replies to post #270126 on Amarin Corp Plc (AMRN)

[Will Lar]

Your numbers are reasonable. Before Du'msday, I thought $10-$15B was a reasonable price tag for a BO.

IF Amarin can mend this ruling somehow without losing a limb, I am wondering if JT will change his strategy in negotiating a BO.

The recent run-up of sp could just be the anticipation of a good earning report this week.

[Triple88]

postes

Maybe values for EU & ROW are at risk IF we lose the appeal and generics roll out a low priced product.

EU does not like to pay more for a bio equivalent drug vs what the market commands in the US. Very rare for drug prices in EU to be higher than the US.

There are several dollars of pricing risk in your model for both EU & ROW assuming there are generics in the US (which I certainly hope never happens !!!)

1.50 in cash
10.00 for EU conservative
2.50 for row very conservative
5.00 for US...extremely conservative
If we win appeal easily 15.00
. Settlement at some point still
5-15.
19.00 bare minimum in my opinion